Skip to Content Facebook Feature Image

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

Business

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates
Business

Business

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

2026-08-25 13:28 Last Updated At:13:45

PORT LOUIS, Mauritius, Aug. 25, 2026 /PRNewswire/ -- STARTRADER evolves alongside global markets, expanding its product range to reflect client interests and trading habits. On 24 August, the company will add 30 new U.S. stock and ETF CFDs to MT5, expanding its range of CFD exposure to companies and themes across technology, infrastructure and innovation.

The expansion spans eight areas. Quantum computing additions include IONQ, QBTS, QUBT, ARQQ and QMCO; software infrastructure includes ZS, S, RBRK and GTLB; space and defence includes LUNR, PL, RCAT and BKSY; while XE and NNE expand the range of CFDs linked to nuclear and energy themes.

The launch also adds SERV and POET across AI and semiconductors; VCX across asset management; DOCN and FROG across cloud and DevOps; and FUTU, ONDS, OUST, VSAT, LASR, AEHR, UCTT and GSAT across fintech, communications and advanced technology. Thematic ETFs DXYZ and NASA complete the release.

The addition caps STARTRADER's most active year of product development. In 2026, the company announced 330+ instruments, extended trading hours across selected stock and ETF instruments, and launched XAUUSD247, its 24/7 gold CFD, all driven by one goal: giving clients greater choice as markets evolve.

The new instruments will be available on MT5 with 1:5 leverage, trade sizes from 0.1 to 1,000 lots, and trading hours from Monday to Friday, 16:30–23:00 GMT+3. Availability depends on account type, client classification and jurisdiction; the instrument is not available to clients in all countries.

The latest release reflects STARTRADER's pillars of Strength, Trust, Ambition and Resilience through broader choice, continuous innovation and an offering designed to adapt with clients and markets.

Risk Warning: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.

Disclaimer: For informational purposes only. Not financial or investment advice or a recommendation to trade. Not for distribution or use where prohibited by applicable law or regulation.

About STARTRADER

STARTRADER is a global multi-asset broker empowering retail and institutional partners to access global markets through a range of platforms, including MetaTrader, STARTRADER APP, and STAR Copy.

STARTRADER operates through entities licensed and regulated by authorities including CMA, ASIC, FSCA, FSA and FSC, combining strong governance with a client-first approach, serving both retail clients and partners with a commitment to transparency, reliability, and long-term growth.

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

STARTRADER Adds 30 U.S. Stock and ETF CFDs as 2026 Product Expansion Accelerates

SEOUL, South Korea, Aug. 25, 2026 /PRNewswire/ -- Classys Inc. (KOSDAQ: 214150) expects device sales worldwide to surpass 50,000 units this year.

As of the end of June, Classys had a cumulative global installed base of more than 22,000 units for its flagship HIFU line and more than 4,000 units for its MRF line. Its MNRF and dermabrasion product lines have also each surpassed 6,000 cumulative global installations. Classys plans to leverage this established footprint to introduce next-generation platforms and create additional avenues for growth through the global rollout of Quadessy and the planned European launch of Viclara later this year.

A well-established sales infrastructure underpins this global expansion. The domestic Korean market, which accounts for approximately 25% of total revenue, serves as a key test market for validating new products and clinical treatment protocols while strengthening the company's global brand competitiveness. The ability to introduce next-generation devices through this existing distribution infrastructure is expected to serve as a key driver of future growth.

This expanding commercial foundation continues to translate into strong financial performance. Classys reported consolidated revenue of KRW 192.7 billion for the first half of the year, representing a 20% year-over-year increase. Even excluding the impact of consolidating its Brazilian subsidiary, growth across existing international markets remained robust. Excluding shipments from Classys headquarters to its Brazilian subsidiary, 1H26 export sales increased 29% year over year, demonstrating that demand for Classys products continues to grow across its existing global markets beyond the impact of the transition to direct sales in Brazil.

In Europe, market diversification delivered tangible results, driven by expansion into new countries—including the UK, Sweden, the Netherlands, Finland, Hungary, and Bulgaria—as well as sales growth in existing European markets. Despite continued investments in global commercialization and market expansion, Classys maintained strong profitability, achieving a standalone operating margin of 50.8% in the first half of the year.

The expansion of the installed base is also significant, as it supports recurring consumables revenue and the adoption of multi-device combination treatments. In the first half of the year, consumables revenue reached KRW 80.2 billion, up 5.3% year over year and 52.7% from the first half of 2024. As cumulative global device installations continue to grow, the foundation for stable, recurring consumables revenue is expanding accordingly.

View Full Article: https://www.prnewswire.com/news-releases/classys-nears-50-000-devices-sold-globally-as-full-lineup-growth-accelerates-302858977

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Classys Nears 50,000 Devices Sold Globally as Full-Lineup Growth Accelerates

Classys Nears 50,000 Devices Sold Globally as Full-Lineup Growth Accelerates

Recommended Articles